Xiuqi Qian

Title: Xiuqi Qian: Innovator in Allergy Treatment

Introduction

Xiuqi Qian is a notable inventor based in Concord, MA (US). He has made significant contributions to the field of allergy treatment through his innovative research and patent work. His expertise lies in developing chemical agents that can inhibit allergic responses, which has important implications for various clinical conditions.

Latest Patents

Xiuqi Qian holds a patent for the "Inhibition of the binding human IgE to its receptor by tetracyclic." This patent discloses chemical agents with unexpected activity to inhibit the interactions between human immunoglobulin E (IgE) and its receptor (Fc.epsilon.RI). These interactions are known to trigger allergic responses. The agents developed by Qian may be used to modulate the allergic response in the treatment of conditions such as rhinitis, asthma, urticaria, atopic dermatitis, and anaphylactic shock. They can be formulated for oral, topical, or parenteral administration.

Career Highlights

Throughout his career, Xiuqi Qian has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notable among these are Heska Corporation and Merck Patent GmbH. His work in these organizations has allowed him to advance his research and contribute to the development of innovative treatments for allergies.

Collaborations

Xiuqi Qian has collaborated with several professionals in his field, including Y-s Edmond Cheng and Yuan Liu. These collaborations have enriched his research and have been instrumental in the development of his patented technologies.

Conclusion

Xiuqi Qian is a distinguished inventor whose work in allergy treatment has the potential to improve the lives of many individuals suffering from allergic conditions. His innovative approach and dedication to research continue to make a significant impact in the medical field.